These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25976389)

  • 1. The chronic lymphocytic leukaemia market.
    Esencay M; Hamad B
    Nat Rev Drug Discov; 2015 Jun; 14(6):381-2. PubMed ID: 25976389
    [No Abstract]   [Full Text] [Related]  

  • 2. A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia.
    Haines I; Elliott P; Stanley R
    Intern Med J; 2009 Apr; 39(4):269-71. PubMed ID: 19402870
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia.
    Oscier D; Fegan C; Hillmen P; Illidge T; Johnson S; Maguire P; Matutes E; Milligan D;
    Br J Haematol; 2004 May; 125(3):294-317. PubMed ID: 15086411
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
    De Padua L; Laurenti L; Falcucci P; D'arena G; Vannata B; Innocenti I; Autore F; Piccirillo N; Za T; Marietti S; Efremov DG; Sica S
    Ann Hematol; 2014 Jul; 93(7):1261-2. PubMed ID: 24306088
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous occurrence of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia.
    Bueno J; Irriguible MD; Palacio C
    Haematologica; 2002 Apr; 87(4):EIM11. PubMed ID: 11940498
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary: chronic lymphocytic leukemia--the price of progress.
    Shanafelt TD; Gunderson H; Call TG
    Oncologist; 2010; 15(6):601-2. PubMed ID: 20463087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to improve the treatment outcome in chronic lymphocytic leukemia?
    Robak T
    Leuk Res; 2010 Mar; 34(3):272-5. PubMed ID: 19682742
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract]   [Full Text] [Related]  

  • 9. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
    Tallman MS; Hakimian D
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic lymphocytic and prolymphocytic leukemia].
    Gerrits CJ; Michiels JJ
    Ned Tijdschr Geneeskd; 1995 Apr; 139(16):826-30. PubMed ID: 7731474
    [No Abstract]   [Full Text] [Related]  

  • 11. [62-year-old patient with chronic lymphatic leukaemia and persistent fever in chemotherapy induced bone marrow aplasia. Angioinvasive aspergillosis].
    Michels G; Bovenschulte H; Cornely OA; Kochanek M
    Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1477-8. PubMed ID: 21567356
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL).
    Bloor A; De Cock E; Hatswell AJ; Wasiak R; Elvidge J; Stapelkamp C; Hadjivassileva T; Haiderali A; Delgado J
    Br J Haematol; 2015 May; 169(3):449-52. PubMed ID: 25410960
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab-containing therapy for chronic lymphocytic leukaemia.
    Tanimoto T; Sakiyama M; Hori A; Yagasaki F; Kami M
    Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237394
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab-containing therapy for chronic lymphocytic leukaemia.
    Haines I; Elliott P; Stanley R
    Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237393
    [No Abstract]   [Full Text] [Related]  

  • 15. First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis.
    Messori A; Fadda V; Maratea D; Trippoli S
    Ann Hematol; 2015 Jun; 94(6):1003-9. PubMed ID: 25677267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic lymphatic leukemia. Current therapy concepts].
    Hallek M; Bergmann M; Brittinger G; Döhner H; Dreger P; Herold M; Hopfinger G; Jäger U; Knauf W; Nerl C; Rummel M; Schmitt B; Wendtner CM; Emmerich B
    Internist (Berl); 2002 Oct; 43(10):1245-54. PubMed ID: 12524905
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoimmunotherapy in chronic lymphocytic leukemia.
    Stilgenbauer S
    Clin Adv Hematol Oncol; 2010 Dec; 8(12):867-8. PubMed ID: 21326163
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
    Goodrich A
    Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):23-36. PubMed ID: 17474175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
    Nabhan C
    Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is chronic lymphatic leukemia curable?].
    Emmerich B; Dengler R
    Dtsch Med Wochenschr; 1992 Feb; 117(8):313-5. PubMed ID: 1537270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.